CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 89 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $3,659,000 | +63.4% | 30,897 | +41.0% | 0.02% | +45.5% |
| Q2 2020 | $2,239,000 | +45.8% | 21,912 | +53.9% | 0.01% | +10.0% |
| Q1 2020 | $1,536,000 | -91.5% | 14,234 | -90.8% | 0.01% | -83.3% |
| Q4 2019 | $18,103,000 | +143.0% | 155,561 | +139.0% | 0.06% | +114.3% |
| Q3 2019 | $7,451,000 | +62.2% | 65,092 | +7.5% | 0.03% | +40.0% |
| Q4 2018 | $4,595,000 | +6.1% | 60,540 | +11.9% | 0.02% | +25.0% |
| Q3 2018 | $4,330,000 | -45.5% | 54,120 | -32.4% | 0.02% | -51.5% |
| Q2 2018 | $7,950,000 | – | 80,037 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Maso Capital Partners Ltd | 164,500 | $15,011,000 | 10.32% |
| HHLR ADVISORS, LTD. | 2,751,200 | $251,047,000 | 6.99% |
| Dalton Investments, Inc. | 113,851 | $10,389,000 | 4.54% |
| Point72 Hong Kong Ltd | 115,939 | $10,579,000 | 4.17% |
| York Capital Management Global Advisors, LLC | 991,233 | $90,450,000 | 4.05% |
| RUDMAN ERROL M | 58,000 | $5,293,000 | 3.57% |
| Greenwoods Asset Management Ltd | 479,580 | $43,762,000 | 2.69% |
| Parametrica Management Ltd | 3,663 | $334,000 | 0.71% |
| Temasek Holdings (Private) Ltd | 990,000 | $90,338,000 | 0.62% |
| Athos Capital Ltd | 8,290 | $756,000 | 0.49% |